If you would like to submit a blog post for consideration, please email firstname.lastname@example.org
A multi-centre study has explored the prevalence of melanoma on hairy scalps in comparison to bald scalps. Associate Professor Giuseppe Argenziano explains in this skin cancer update video that – while around 76 percent of scalp melanomas are found on people with thinning or no hair – a quarter appear on people with hairy scalps.
Scalp melanoma can be aggressive and has a poorer prognosis compared to melanoma found elsewhere on the body, because scalp melanoma is generally thicker at the time of diagnosis. It also looks different depending on where it is located on the scalp itself, making it trickier to identify. Continue reading “Skin Cancer Update with A/Prof Giuseppe Argenziano [January 2018]”
Modern therapies for cutaneous lymphomas were a topic of discussion at the European Academy of Dermatology and Venereology 2017 Congress, which was held in Geneva in September 2017. Continue reading “Cutaneous Lymphomas: New Therapies in Development”
How does suturing technique affect cosmetic outcomes after facial surgery? Recent research published in the Journal of the American Academy of Dermatology sought to compare the cosmetic results of simple interrupted sutures versus running subcuticular sutures in facial surgery.
In a controlled trial, adults receiving dermatologic surgery on the face (for conditions such as skin cancer) were randomised to receive either simple interrupted sutures (73 patients) or running subcuticular sutures (69 patients). Continue reading “Suturing Technique for Best Cosmetic Outcomes”
Do we need pigment to develop melanoma? This question was discussed at the 2017 European Academy of Dermatology and Venereology by Professor David E Fisher, who presented interesting findings in melanoma research.
Research shows that black mice with BRAF mutations that activate the RAS/RAF/MEK/ERK pathway develop multiple nevi. On the other hand, 50 percent of red mice with the same changes develop melanoma without being exposed to UV light. If the red mice are albino, no melanoma appears. Continue reading “Do we need pigment to develop melanoma?”
Sunscreen is more effective than shade at protecting the skin from sunburn, although neither approach alone can completely prevent it, according to recent research.
Researchers in Lake Lewisville, Texas, sought to discover how well shade from a beach umbrella protects against sunburn and how it compares with protection provided by high-SPF sunscreen. Continue reading “What is the best protection against sunburn?”
In this month’s skin cancer update video, Associate Professor Giuseppe Argenziano discusses which adjuvant therapies are most effective in the treatment of advanced melanoma.
In stage 3 melanoma patients who have their primary tumour surgically excised, five-year recurrence rates are 70 percent in patients who receive no adjuvant therapy; 64 percent in patients who receive Interferon; 59 percent in patients who receive Ipilimumab; 38 percent in patients who receive Nivolumab; and 37 percent in patients who receive a combination of target therapies. Continue reading “Skin Cancer Update with A/Prof Giuseppe Argenziano [November]”
Drinking alcohol increases a person’s risk of developing non-melanoma skin cancer, according to a review published in British Journal of Dermatology.
Previously, the association between alcohol intake and non-melanoma skin cancer – which mainly comprises of basal cell carcinoma and cutaneous squamous cell carcinoma – was inconclusive. Therefore, the objective of the recent review was to quantify the relationship between alcohol intake and non-melanoma skin cancer using meta-analysis. Continue reading “Alcohol Increases Risk of Skin Cancer”
We know that dermoscopy provides us with more information than is possible with the naked eye. The trick is to understand what the additional information means, and what we should do with it! This is where research on dermoscopy and management guidelines is so important. In this case, we are particularly looking at the management of Spitz nevi. Continue reading “Management Guidelines for Dermoscopy of Spitz Nevi”
A ‘groundbreaking’ immunotherapy drug is helping patients overcome advanced non-melanoma skin cancer.
Cemiplimab is being used at Sir Charles Gaidner Hospital in Perth as part of an international trial. Oncologist Annette Lim, who runs the trial, says most patients have responded with encouraging results.
There were strict criteria for patients to enter the trial, but early results suggest the drug could be a game-changer for non-melanoma skin cancer sufferers. Continue reading “Groundbreaking Immunotherapy Drug Beats Skin Cancer”
A new research centre in Brisbane will test a variety of products that claim to be sun safe.
Queensland University of Technology (QUT) is partnering with Q-Pharm to open its Centre for Testing New Technology, which will test lotions, apps, patches and wearables, and any other products that promise to protect users from the sun. Continue reading “Sun Safe Devices Put To The Test”